Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency): A Double-blind, Randomized, Placebo-controlled Study

NCT05579327 is registered in ClinicalTrials.gov with Rare Thyroid Therapeutics International AB as lead sponsor.

NCT NCT05579327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05579327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency): A Double-blind, Randomized, Placebo-controlled Study
Lead sponsor
Rare Thyroid Therapeutics International AB
Phase
Phase 3
Overall status
Completed
Start date
July 21, 2023
Completion date
September 3, 2025
Enrollment
20 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

allan-herndon-dudley syndrome, monocarboxylate transporter 8 deficiency